Nuance Audio hearing aid glasses receive FDA approval as a medical device

News
Article

EssilorLuxottica’s Nuance Audio glasses, which are equipped with hearing aids, will be available over the counter in the US and Europe as soon as Q1 2025.

Nuance Audio glasses receive FDA approval and CE mark for software as a medical device - Image credit: Adobe Stock / ©Svetlana

(Image credit: Adobe Stock / ©Svetlana.jpeg)

EssilorLuxottica has received medical device approval from the FDA for its over-the-counter Nuance Audio Glasses, which integrates open-ear hearing aid into a pair of smart glasses. Concurrently, the device received CE marking under the Medical Devices Regulation in the EU as well as an ISO Quality Management System certification for Hearing Aids. The sweep of approvals will allow the glasses to launch in the US and Europe simultaneously.1

“Two years ago, we set out to create a first-of-its-kind product that would change the way people see and hear. We didn’t just aim to combine two medical devices – we created an entirely new smart glasses form factor to support the two human senses we depend on the most. It is not only groundbreaking, but also incredibly accessible. We’re pleased now to turn our focus to getting this life-changing technology into the hands of people around the world who truly need it,” Francesco Milleri, Chairman and CEO of EssilorLuxottica, said in a press release.

Nuance Audio pairs a stylish frame and an open-ear hearing device to help patients who need both assistive devices navigate their world a bit easier. (Image courtesy of EssilorLuxottica)

Nuance Audio pairs a stylish frame and an open-ear hearing device to help patients who need both assistive devices navigate their world a bit easier. (Image courtesy of EssilorLuxottica)

Nuance Audio Hearing Aid Software is the first Software as Medical Device (SaMD) to received FDA clearance in the US. The smart glasses combine stylish frames with an open-ear hearing aid, which reduces crowding around the ear that happens when using both a hearing aid and glasses. “After decades of adoption barriers ranging from comfort to visibility, consumers will finally be able to see clearly and hear clearly with a single product that is both beautiful and highly functional,” the press release reads.

Following the FDA approval and CE marking, Nuance Audio Glasses will be available for over-the-counter purchase in Q1 2025 in the US, and European rollout will begin in Italy in Q1 2025, then will expand to include France, Germany, UK, and additional unnamed European markets progressively over the first half of 2025. Eye care providers in the United States are invited to complete an interest form or contact their EssilorLuxottica representative for first access to the device.

According to the press release, EssilorLuxottica’s aim in creating Nuance Audio was to tackle hearing device disuse due to stigma, discomfort, cost, and limited accessibility. According to the World Health Organization’s 2021 World Report on Hearing, approximately 1.25 billion people worldwide experience mild to moderate hearing loss.2 With the introduction of Nuance Audio, EssilorLuxottica hopes to encourage more widespread adoption of hearing aids without sacrificing visual acuity.

References
1. EssilorLuxottica receives FDA clearance and EU certifications for Nuance Audio, making it available to consumers in the U.S. and Europe. EssilorLuxottica. Press release. Published February 3, 2025. Accessed February 3, 2025. https://www.essilorluxottica.com/en/newsroom/press-releases/fda-clearance-and-eu-certifications-for-nuance-audio/
2. World Health Organization, World Report on Hearing, 2021, p. 40.
Recent Videos
The California Optometric Association and the Los Angeles County Optometric Society have compiled resources for optometrists to get involved in continuing relief efforts.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Dr. Mile Brujic discusses a case series on a novel gel for lacrimal occlusion.
Dr. Julie Rodman discusses retina, imaging, and posterior segment in SECO presentations
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Alysse Henkel, vice president of Research and inSights at The Vision Council, advised that expanding budget and mid-market frame options may help improve frames sales.
With an additional 10% increase in tariffs to China, and a 25% increase in tariffs in Canada and Mexico looming, the optical industry is anticipating to pay as much as double in tariff costs compared to last year.
Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.
Although 2025 is predicted to remain stable, the forecast for the optical industry still remains uncertain.
Steven T. Reed, OD, talks Optometry's Meeting and public-facing initiatives that optometrists can take advantage of.
© 2025 MJH Life Sciences

All rights reserved.